Sign In
Buy OGEN
$0.610
+0 (+0%)
At Close: Jun 03, 2026
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
OGEN: Acquires Noachis Terra Inc.; Will Develop SARS-CoV-2 Vaccine…
09:45am, Friday, 08'th May 2020
By David Bautz, PhD NASDAQ:BCLI READ THE FULL OGEN RESEARCH REPORT Business Update Developing Vaccine Against SARS-CoV-2 On May 4, 2020, Oragenics, Inc. (OGEN) announced the acquisition of Noachis Ter
Precigen, Inc. (PGEN) CEO Helen Sabzevari on Q1 2020 Results - Earnings Call Transcript
02:24am, Thursday, 07'th May 2020
Precigen, Inc. (NASDAQ:PGEN) Q1 2020 Earnings Conference Call May 06, 2020, 16:15 ET Company Participants Steven Harasym - VP, IR Helen Sabzevari - President &a
8-K: ORAGENICS INC
11:35pm, Monday, 04'th May 2020
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange...
Oragenics Announces New Member of the Board of Directors
10:15am, Monday, 04'th May 2020
Oragenics Announces New Member of the Board of Directors
Oragenics Acquires Noachis Terra Inc., To Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing "Spike Protein"
